Devalingam Mahalingam, PhD

Devalingam Mahalingam, PhD, Northwestern Feinberg School of Medicine

Articles by Devalingam Mahalingam, PhD

Devalingam Mahalingam, PhDPancreatic Cancer | June 2, 2025
Dr. Mahalingam shares preliminary results from the randomized phase 2 study of elraglusib with gemcitabine/nab-paclitaxel.
View More